Researchers investigated whether treatment with ursodeoxycholic acid affected still birth and preterm birth in women with intrahepatic cholestasis of pregnancy.
Researchers evaluated the correlation of liver fibrosis and steatosis with diabetic peripheral neuropathy in patients with type 2 diabetes.
Investigators sought to determine disparities in liver cancer surveillance among patients with disabilities.
HyperHEP B is the Grifol’s new formulation of its hepatitis B immune globulin.
The authors noted that DILI remains a diagnosis of exclusion based on a detailed history and use of blood tests, hepatobiliary imaging, and liver biopsy.
Researchers investigated the efficacy of lumasiran in the reduction of hepatic oxalate production.
Researchers compared the cost-effectiveness of atezolizumab plus bevacizumab vs sorafenib for patients with unresectable or metastatic hepatocellular carcinoma.
The FDA has identified 25 cases of serious liver injury leading to liver decompensation or liver failure associated with Ocaliva in PBC patients with compensated or decompensated cirrhosis.
Researchers assessed the influence of direct-acting antivirals on gut microbiota by analyzing microbial diversity and composition in patients with hepatitis C virus infection with or without HIV.
Patients with current or past HBV infection are not at greater risk for liver injury or mortality during COVID-19 infection.
Drug-induced liver injury (DILI) has an incidence of 0.32 percent among hospitalized patients, and risk factors include hyperlipidemia, cardiovascular disease, preexisting liver disease, and surgical history.
Investigators examined the safety and efficacy of SGLT2i and GLP-1RA on treatment of nonalcoholic fatty liver disease in type 2 diabetes mellitus.
Researchers assessed cardiac biomarkers, among other clinical factors, associated with severe CAD in patients with NAFLD.
Investigators analyzed the safety of tenofovir disoproxil fumarate therapy during the third trimester of pregnancy.
Researchers conducted a randomized trial comparing specimen quality and financial costs between PC and EUS-guided liver biopsy methods.
Investigators compared the effects of moderate-intensity aerobic vs resistance exercise with dietary modifications in patients with NAFLD.
Researchers reviewed the effects of direct-acting antiviral therapies on the extrahepatic manifestations of HCV.
Researchers analyzed the genomes of children with chronic cholestasis for gene variants not typically associated with liver disease.
In this featured study from the New England Journal of Medicine, British researchers share the results of a phase 2 trial for semaglutide in 230 patients with NASH.
While pediatric liver tumors remain rare, their diagnosis and treatment requires a systematic approach from a multi-professional team of clinicians.